CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
CTS Charlotte Lab successfully implemented WNV NAT testing on the Panther Testing Platform on Monday...
Daylight Saving Time Begins March 10, 2019. As a friendly reminder, airlines often change their rout...
On April 15, 2019, the New CTS Laboratory Information System has been successfully implemented in Po...
The FDA Guidance ZIKV video for the webinar held on 08/15/18 has been posted in the Wh...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
Dr. Buff Mair is the new CTS Medical Director and replaces Dr. German Leparc who retired at the begi...